Literature DB >> 21076280

A patient with 'spontaneous' heparin-induced thrombocytopenia and thrombosis after undergoing knee replacement.

Alka Mallik1, Karen B Carlson, Maria T DeSancho.   

Abstract

Exogenous heparin exposure is the major risk factor for heparin-induced thrombocytopenia and thrombosis (HITT). To date, only five cases of 'spontaneous' HITT have been reported in the literature. We report the case of a 60-year-old man who developed severe thrombocytopenia (15 000/μl) and bilateral deep venous thromboses 10 days after bilateral knee replacement. There was no evidence of heparin exposure upon review of the patient's preoperative and postoperative medication history. Heparin: platelet factor-4 (PF4) antibodies were positive as was the serotonin release assay. Anticoagulation with argatroban along with prednisone and intravenous immune globulin were administered. Anticoagulation with argatroban was bridged to warfarin once his platelet count reached 100 000/μl, and he was continued on oral prednisone taper. Heparin: PF4 antibodies were negative 3 months after the event. Six months later, Doppler ultrasound revealed deep vein thrombosis. This case represents a third 'spontaneous' episode of HITT in the context of knee replacement surgery without heparin administration. It is unclear whether these cases are a result of exposure to a heparin-like proteoglycan such as chondroitin sulfate during surgery that binds PF4, or whether the perioperative pro-inflammatory milieu is the inciting event. Further consideration of precipitating events in these individuals merits further investigation and may lead to valuable insight into the pathophysiology of heparin-independent PF4-related thrombocytopenia and thrombosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21076280     DOI: 10.1097/MBC.0b013e328340ff11

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  8 in total

1.  Use of intravenous immunoglobulin G to treat spontaneous heparin-induced thrombocytopenia.

Authors:  Mehraboon Irani; Eric Siegal; Abhay Jella; Richard Aster; Anand Padmanabhan
Journal:  Transfusion       Date:  2018-12-17       Impact factor: 3.157

Review 2.  Heparin-Induced Thrombocytopenia: A Focus on Thrombosis.

Authors:  Gowthami M Arepally; Anand Padmanabhan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-12-03       Impact factor: 8.311

3.  Reduced induction of anti-PF4/heparin antibody in RA patients after total knee arthroplasty.

Authors:  Masahiro Izumi; Tatsuya Sakai; Atsunori Shirakawa; Hideko Kozuru; Yuka Jiuchi; Yasumori Izumi; Tomohiko Asahara; Kenji Kumagai; Masaaki Mawatari; Makoto Osaki; Satoru Motokawa; Kiyoshi Migita
Journal:  Arthritis Res Ther       Date:  2016-08-25       Impact factor: 5.156

4.  Spontaneous heparin-induced thrombocytopenia presenting as bilateral adrenal hemorrhages and pulmonary embolism after total knee arthroplasty.

Authors:  Amro Elshoury; Maha Khedr; Mostafa M Abousayed; Syed Mehdi
Journal:  Arthroplast Today       Date:  2015-09-05

Review 5.  The Non-Hemostatic Aspects of Transfused Platelets.

Authors:  Caroline Sut; Sofiane Tariket; Cécile Aubron; Chaker Aloui; Hind Hamzeh-Cognasse; Philippe Berthelot; Sandrine Laradi; Andreas Greinacher; Olivier Garraud; Fabrice Cognasse
Journal:  Front Med (Lausanne)       Date:  2018-02-27

Review 6.  Functional Assays in the Diagnosis of Heparin-Induced Thrombocytopenia: A Review.

Authors:  Valentine Minet; Jean-Michel Dogné; François Mullier
Journal:  Molecules       Date:  2017-04-11       Impact factor: 4.411

7.  Profiling Heparin-Induced Thrombocytopenia (HIT) Antibodies in Hospitalized Patients With and Without Diabetes.

Authors:  Margaret Prechel; Susan Hudec; Elizabeth Lowden; Vicki Escalante; Nicholas Emanuele; Maryann Emanuele; Jeanine M Walenga
Journal:  Clin Appl Thromb Hemost       Date:  2018-11-12       Impact factor: 2.389

8.  Spontaneous heparin-induced thrombocytopenia syndrome presenting as bilateral adrenal infarction after knee arthroplasty.

Authors:  Elysha A VanderVeer; Raymond P Torbiak; Ally Ph Prebtani; Theodore E Warkentin
Journal:  BMJ Case Rep       Date:  2019-12-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.